ArticleOncotarget2017

Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.